Amphastar Pharmaceuticals, Inc.AMPH

Market cap

$1.2B

P/E ratio

	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Product	-	-	-	-	-	-	-	-	-	593	713
Other	-	-	-	-	-	-	-	-	-	51	19
Revenues	210	252	255	240	295	322	350	438	499	644	732
Cost of Revenue	159	174	151	149	188	190	207	238	250	293	358
Gross profit	51	77	104	91	107	132	143	200	249	351	374
Selling and Marketing Expense	6	5	5	6	8	13	15	17	22	29	38
General and administrative	35	42	42	44	50	50	50	51	45	52	57
Research and development	28	37	41	43	58	69	67	61	75	74	74
Total operating expenses	69	84	88	92	116	132	132	130	141	154	168
Income from operations	-18	-7	16	-1	-9	-0	11	70	107	197	205
Interest income	0	0	0	0	0	1	1	1	1	5	11
Interest expense	-	-	-	-	-	-	-	-	-	-	30
Other income (expenses), net	0	-3	0	3	-2	59	-7	15	9	-4	4
Total non-operating income (expenses), net	-0	-3	-1	3	-1	60	-6	14	9	-26	-16
Income before income taxes	-18	-10	15	2	-10	60	5	84	116	171	190
Income tax provision	-7	-8	4	-3	-3	14	4	21	23	32	30
Income before equity in losses of unconsolidated affiliate	-	-	-	-	-	-	-	64	93	140	160
Income (Loss) from Equity Method Investments	-	-	-	-	-	-	-	-0	-1	-2	-1
Net income attributable to Amphastar Pharmaceuticals, Inc.	-	-	-	-	-7	47	1	63	91	138	160
Net income	-11	-3	11	5	-6	49	1	63	91	138	160
Basic	-0.25	-0.06	0.23	0.1	-0.12	1.04	0.03	1.3	1.88	2.85	3.29
Diluted	-0.25	-0.06	0.22	0.09	-0.12	0.98	0.03	1.25	1.74	2.6	3.06